Pneumonia is an infection that affects one or both lungs. The disease can range from mild to severe and can be fatal. It is typically ...

Just now, the U.S. House of Representatives passed a bipartisan bill which, if enacted, would extend the enhanced healthcare tax credits for three years. American Lung Association President and CEO Ha ...

UCLA Health experts say long-term threats to lung health, mental well-being and overall community wellness remain, long after ...

Spiro Medical, which debuted last year, reeled in $67 million in series A funding it plans to use to develop its novel ...

The system aims to address underlying chronic cough and issues with mucus production and clearance in chronic bronchitis.

Eric Quizon addresses long-standing questions surrounding why his late father, comedy icon Dolphy, has not been named a ...

Early diagnosis of pulmonary arterial hypertension improves five-year survival by 42%, compared with delayed diagnosis, a ...

The first COPD patient has been dosed in a Phase 1b COPD trial testing Bambusa Therapeutics’ dual-target therapy BBT002.

Patients who have comorbid COPD with heart failure and ischemic heart disease have increased health care resource use and higher mortality.

Spiro Medical announced today that it closed a $67 million Series A equity financing to support its neuromodulation system.

About Recludix Recludix is a clinical-stage company with leading, innovative platform approaches to discover and develop potent and selective inhibitors of challenging protein targets. The company’s ...

Mount Sinai analysis looks at the effectiveness of electrocardiograms analyzed via deep learning as a tool for early COPD detection ...